APA (7th ed.) Citation

Meyers, C. D., Amer, A., Majumdar, T., & Chen, J. (2015). Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects. Journal of clinical pharmacology, 55(9), 1031. https://doi.org/10.1002/jcph.509

Chicago Style (17th ed.) Citation

Meyers, Charles D., Ahmed Amer, Tapan Majumdar, and Jin Chen. "Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Pradigastat, a Novel Diacylglycerol Acyltransferase 1 Inhibitor in Overweight or Obese, but Otherwise Healthy Human Subjects." Journal of Clinical Pharmacology 55, no. 9 (2015): 1031. https://doi.org/10.1002/jcph.509.

MLA (9th ed.) Citation

Meyers, Charles D., et al. "Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Pradigastat, a Novel Diacylglycerol Acyltransferase 1 Inhibitor in Overweight or Obese, but Otherwise Healthy Human Subjects." Journal of Clinical Pharmacology, vol. 55, no. 9, 2015, p. 1031, https://doi.org/10.1002/jcph.509.